Dihexa (Nasal Spray)

Dihexa is an investigational, research-grade angiotensin IV analog developed exclusively for laboratory evaluation of cognitive pathways and synapse formation. The compound operates by targeting and activating the hepatocyte growth factor (HGF) and its receptor, c-Met, within preclinical models. Please note that this product is strictly limited to in vitro and laboratory testing; it is not approved by the FDA for human consumption, clinical use, or therapeutic applications.